FDA Prepares To Issue Draft Biomarker Qualifications Guidance
This article was originally published in The Gray Sheet
Executive Summary
FDA will issue draft guidance on qualifying biomarkers for use in drug development studies within the next few months, according to Commissioner Margaret Hamburg